Morphine - Administration & dosage
Research News and Information

Tuesday, November 24, 2009

Central sensory-motor deficit after uneventful single-dose spinal morphine administration in a patient with preexisting migraine headaches.

30 Oct 2009 Hemiplegic migraine is a condition associated with vascular alteration of the central nervous system and transient neurologic deficits. Permanent morphine-induced motor dysfunction has been reported after spinal ischemia. We report a persisting ... Read more...

A randomized controlled trial of pentazocine versus ondansetron for the treatment of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery.

30 Oct 2009 BACKGROUND: Ondansetron is effective for the treatment of intrathecal morphine-induced pruritus. There is evidence that kappa-opioid receptor agonists have antipruritic activity. Pentazocine is an agonist of kappa-opioid receptors and partial ... Read more...

A randomized comparison of low doses of hyperbaric bupivacaine in combined spinal-epidural anesthesia for cesarean delivery.

30 Oct 2009 BACKGROUND: The aim of our study was to investigate the block characteristics of intrathecal hyperbaric bupivacaine 7, 8, or 9 mg administered during combined spinal-epidural anesthesia for cesarean delivery and to elucidate the dose that produces ... Read more...

Latest indexed articles for 'Morphine - Administration & dosage'

These are the very latest articles for this heading:

• Continuous transversus abdominis plane block for renal transplant recipients. 30 Oct 2009
• Central sensory-motor deficit after uneventful single-dose spinal morphine administration in a patient with preexisting migraine headaches. 30 Oct 2009
• A randomized controlled trial of pentazocine versus ondansetron for the treatment of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery. 30 Oct 2009
• A randomized comparison of low doses of hyperbaric bupivacaine in combined spinal-epidural anesthesia for cesarean delivery. 30 Oct 2009
• Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion. 30 Oct 2009
• Craniotomy pain: trying to do better. 30 Oct 2009
• No brain, no pain: does the injured brain stack up opioids? 29 Sep 2009
• Effect of acute inflammatory brain injury on accumulation of morphine and morphine 3- and 6-glucuronide in the human brain. 29 Sep 2009
• The synergistic interaction between morphine and maprotiline after intrathecal injection in rats. 29 Sep 2009
• A comparison of intravenous oxycodone and intravenous morphine in patient-controlled postoperative analgesia after laparoscopic hysterectomy. 29 Sep 2009
• Pediatric nurses' thinking in response to vignettes on administering analgesics. 29 Sep 2009
• Involvement of actin rearrangements within the amygdala and the dorsal hippocampus in aversive memories of drug withdrawal in acute morphine-dependent rats. 28 Sep 2009
• Effects of microinjection of angiotensin II and captopril to VTA on morphine self-administration in rats. 30 Aug 2009
• A randomized controlled trial of bupivacaine through intracostal catheters for pain management after thoracotomy. 30 Aug 2009
• A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults. 26 Aug 2009
• The analgesic effect of gabapentin as a prophylactic anticonvulsant drug on postcraniotomy pain: a prospective randomized study. 25 Aug 2009
• Unnecessary medicines? 30 Jul 2009
• Paracetamol versus metamizol in the treatment of postoperative pain after breast surgery: a randomized, controlled trial. 30 Jul 2009
• The effective duration of analgesia after intrathecal morphine in patients without additional opioid analgesia: a randomized double-blind multicentre study on orthopaedic patients. 30 Jul 2009
• The effects of propofol infusion on hepatic and pancreatic function and acid-base status in children undergoing craniotomy and receiving phenytoin. 30 Jul 2009

See a longer list of these articles.

Technical information about 'Morphine'

Definition: The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.

Chemical name: Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-

Registry Number: 57-27-2

Descriptor UI: D009020

Alternative terms: Morphine; Morphia; Morphine Chloride; Chloride, Morphine; Morphine Sulfate; Sulfate, Morphine; SDZ 202-250; SDZ 202 250; SDZ 202250; SDZ202-250; SDZ202 250; SDZ202250; Morphine Sulfate (2:1), Pentahydrate; MS Contin; Contin, MS; Oramorph SR; Duramorph; Morphine Sulfate (2:1), Anhydrous;

Related Mesh Headings: Receptors, Opioid;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists; biosynthesis;

Pharmacological Action: Analgesics, Opioid; Narcotics;

Tree Number: D03.132.577.249.547; D03.549.686.575; D03.605.497.575; D04.615.723.795.547;

History Note: MORPHINE SULFATE was (NM) 1980-96

Technical Notes: /analogs = MORPHINE DERIVATIVES